Innovation & intellectual property · 06/11/20261 min read
EPO and Medicines for Europe deepen dialogue on patent quality
Summary
Discussions in Munich cover divisional applications, third-party observations and developments in healthcare
Original source language: European Patent Office NewsOpen original release →